[Efficacy and Safety of Crizotinib in Advanced or Recurrent ALK-positive Non-small Cell Lung Cancer]. [electronic resource]
Producer: 20200103Description: 488-493 p. digitalISSN:- 1999-6187
- Adult
- Aged
- Anaplastic Lymphoma Kinase -- genetics
- Antineoplastic Agents -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Crizotinib -- administration & dosage
- Disease-Free Survival
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Protein Kinase Inhibitors -- administration & dosage
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.